Cardiac Tamponade Secondary to COVID-19

Area of Science:

• Cardiology
• Infectious Diseases
• Critical Care Medicine

Background:

• Coronavirus disease-2019 (COVID-19) can present with diverse cardiac manifestations.
• Pericardial effusion and takotsubo cardiomyopathy are recognized, though less common, complications of viral infections.

Observation:

• A 67-year-old woman with COVID-19 presented with respiratory symptoms.
• Echocardiography revealed a large hemorrhagic pericardial effusion, indicating cardiac tamponade.
• The patient also exhibited mild left ventricular impairment and developed takotsubo cardiomyopathy during her clinical course.

Findings:

• The patient underwent pericardiocentesis to relieve the pericardial effusion and cardiac tamponade.
• Medical management included colchicine, corticosteroids, and hydroxychloroquine.
• The combination of interventions resulted in significant improvement of her symptoms and cardiac function.

Implications:

• This case highlights the potential for severe cardiac complications in COVID-19, including tamponade and takotsubo cardiomyopathy.
• Multimodal treatment approaches may be effective in managing these complex cardiovascular manifestations.
• Further research is warranted to elucidate the mechanisms linking COVID-19 to these cardiac conditions and to optimize therapeutic strategies.